Pharmaceutical and Biotech Insight, News and Blog Posts

DelveInsight Blog

Map the latest in Pharmaceutical, Healthcare, Medical Devices and Biotech Space with DelveInsight’s panoramic market analysis while the Pharma Industry continues to rapidly evolve with several approvals,failures, acquisitions, and partnerships teeing up the domain.

The Future Of Medicinal Care – Medical Robots

Today’s healthcare industry utilizes many types of robots to improve the current standard of care and help humans do the things that they were not able to do in the past, that too more quickly and with fewer errors. Definitely, some might feel uncomfortable with the idea of robots assisting in medical operations or comforting...

Merck’s Gefapixant; Pfizer’s Somatrogon; Gilead’s Viklury; AbbVie’s Skyrizi; Gilead’s...

Merck’s Chronic Cough Med Gefapixant Receives A Red Flag From the FDA, Requests For More Data On 24th January 2022, Merck & Co. announced FDA rejection for its New Drug Application (NDA) of Gefapixant (experimental drug) for unexplained or chronic cough. FDA asked for additional information on the drug, related only to th...

pharma-news-for-merck-pfizer-gilead-abbvie-lantern-polpharma

How Technology is Providing a New Dimension to the Clinical Trials?

Highlights: The key challenges in the clinical trials processes such as slow recruitment, data management, lack of diversity, compliance with several rules and regulations, and others faced by the organizations.The impact of technology in clinical trials from recruiting more quickly to remote monitoring and improving patient ...

advent-of-technology-in-clinical-trials
drugs-launched-in-second-half-2021
Assessment of Key Products that Got FDA Approva...

More than 20+ drugs by leading pharma players including Novartis, Sanofi, and others re...

car-t-cell-therapy-market-competitive-landscape-key-players
CAR-T Cell Therapy aka Miraculous Technology: M...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

contract-organizations-impacting-pharma-development-and-manufacturing
Contract Organizations Impacting Pharma Develop...

Contract Development and Manufacturing Organisation (CDMO) is a term for organizations ...

Our Consulting Services

Optimized, competent, and dependable solutions to tackle fast-paced pharma market challenges.

Our Consulting Services
Our Pharma Market Reports

Credible, data-driven, & analytical pharma & biotech market research & analysis for a holistic understanding.

Our Pharma Market Reports
Our MedTech Insights

Clinical solutions for vastly expanding diagnostics, digital therapeutics, and the MedTech industry.

Our MedTech Insights
Editor's Pick
22 Healthcare Trends & Innovations to Watch in 2022 and Beyond

With the advent of new-age healthcare industry trends that are evident as of now, there...

Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021

Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...

Analyzing the Key Trends Driving the Biosimilar Market Growth

The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...

CAR-T Cell Therapy aka Miraculous Technology: Mapping the Market, Approved Th...

Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...

Myelodysplastic Syndromes (MDS): Key Pharma Players Unveiling Updated Finding...

There has been limited progress in the approval of novel agents in MDS. It has been a l...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.